213 related articles for article (PubMed ID: 27752808)
1. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life.
Muir J; Aronson M; Esplen MJ; Pollett A; Swallow CJ
J Gastrointest Surg; 2016 Dec; 20(12):1950-1958. PubMed ID: 27752808
[TBL] [Abstract][Full Text] [Related]
2. Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.
McGarragle KM; Hart TL; Swallow C; Brar S; Govindarajan A; Cohen Z; Aronson M
Fam Cancer; 2021 Apr; 20(2):157-169. PubMed ID: 32754788
[TBL] [Abstract][Full Text] [Related]
3. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
[No Abstract] [Full Text] [Related]
5. The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study.
Worster E; Liu X; Richardson S; Hardwick RH; Dwerryhouse S; Caldas C; Fitzgerald RC
Ann Surg; 2014 Jul; 260(1):87-93. PubMed ID: 24424140
[TBL] [Abstract][Full Text] [Related]
6. The Psychosocial Impact of Undergoing Prophylactic Total Gastrectomy (PTG) to Manage the Risk of Hereditary Diffuse Gastric Cancer (HDGC).
Hallowell N; Lawton J; Badger S; Richardson S; Hardwick RH; Caldas C; Fitzgerald RC
J Genet Couns; 2017 Aug; 26(4):752-762. PubMed ID: 27837291
[TBL] [Abstract][Full Text] [Related]
7. Decision-making and regret in patients with germline
Gamble LA; Grant RRC; Samaranayake SG; Fasaye GA; Koh C; Korman L; Asif B; Heller T; Hernandez JM; Blakely AM; Davis JL
J Med Genet; 2023 Mar; 60(3):241-246. PubMed ID: 35817563
[TBL] [Abstract][Full Text] [Related]
8. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients.
Strong VE; Gholami S; Shah MA; Tang LH; Janjigian YY; Schattner M; Selby LV; Yoon SS; Salo-Mullen E; Stadler ZK; Kelsen D; Brennan MF; Coit DG
Ann Surg; 2017 Dec; 266(6):1006-1012. PubMed ID: 27759617
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
[TBL] [Abstract][Full Text] [Related]
10. International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study.
Roberts G; Benusiglio PR; Bisseling T; Coit D; Davis JL; Grimes S; Guise TA; Hardwick R; Harris K; Mansfield PF; Rossaak J; Schreiber KC; Stanich PP; Strong VE; Kaurah P;
Gastric Cancer; 2022 Nov; 25(6):1094-1104. PubMed ID: 35831514
[TBL] [Abstract][Full Text] [Related]
11. Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene.
Stillman MD; Kusche N; Toledano S; Hilfrank KJ; Yoon C; Gabre JT; Rustgi SD; Hur C; Kastrinos F; Ryeom SW; Yoon SS
J Surg Oncol; 2022 Dec; 126(8):1413-1422. PubMed ID: 36063148
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic prophylactic total gastrectomy with limited lymphadenectomy for CDH1 gene carriers.
Bryant MK; Sillcox R; Grady WM; Oelschlager BK
Surg Endosc; 2023 Dec; 37(12):9373-9380. PubMed ID: 37644154
[TBL] [Abstract][Full Text] [Related]
13. Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience.
DiBrito SR; Blair AB; Prasath V; Habibi M; Harmon JW; Duncan MD
J Surg Res; 2020 Mar; 247():438-444. PubMed ID: 31685251
[TBL] [Abstract][Full Text] [Related]
14. Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1.
Laszkowska M; Silver ER; Schrope B; Kastrinos F; Wang TC; Hur C
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):822-829.e4. PubMed ID: 31220641
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic total gastrectomy for individuals with germline CDH1 mutation.
Pandalai PK; Lauwers GY; Chung DC; Patel D; Yoon SS
Surgery; 2011 Mar; 149(3):347-55. PubMed ID: 20719348
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation.
Haverkamp L; van der Sluis PC; Ausems MG; van der Horst S; Siersema PD; Ruurda JP; Offerhaus GJ; van Hillegersberg R
J Gastrointest Surg; 2015 Dec; 19(12):2120-5. PubMed ID: 26443527
[TBL] [Abstract][Full Text] [Related]
17. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
[TBL] [Abstract][Full Text] [Related]
18. Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations.
Corso G; Magnoni F; Nicastro V; Bagnardi V; Trovato CM; Veronesi P
Semin Oncol; 2022 Apr; 49(2):130-135. PubMed ID: 35393124
[TBL] [Abstract][Full Text] [Related]
19. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
Cisco RM; Ford JM; Norton JA
Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
[TBL] [Abstract][Full Text] [Related]
20. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]